Remove 11 17 pharma-law-policy-october-2022
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022. 30 of 2022.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

ANVISA Publishes New Measures to Prohibit Cosmetic Products Used in Injectable Form, 10 October 2023 ANVISA published two resolutions that suspended the trade, distribution, manufacture, advertising, and use of products from PHD Cosméticos Ltda. and Biometik Indústria e Comércio de Cosméticos.

FDA 52